James Investment Research Inc. cut its stake in shares of Aetna Inc (NYSE:AET) by 13.7% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 82,040 shares of the company’s stock after selling 12,975 shares during the period. James Investment Research Inc.’s holdings in Aetna were worth $14,799,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in AET. GSA Capital Partners LLP purchased a new position in Aetna during the second quarter valued at $350,000. D.A. Davidson & CO. lifted its position in Aetna by 3.2% during the second quarter. D.A. Davidson & CO. now owns 7,341 shares of the company’s stock valued at $1,114,000 after purchasing an additional 225 shares in the last quarter. FIL Ltd purchased a new position in Aetna during the second quarter valued at $8,646,000. Advisor Group Inc. lifted its position in Aetna by 23.2% during the second quarter. Advisor Group Inc. now owns 16,292 shares of the company’s stock valued at $2,453,000 after purchasing an additional 3,073 shares in the last quarter. Finally, Veritable L.P. lifted its position in Aetna by 0.9% during the second quarter. Veritable L.P. now owns 10,763 shares of the company’s stock valued at $1,634,000 after purchasing an additional 94 shares in the last quarter. Institutional investors own 87.88% of the company’s stock.

Aetna Inc (NYSE:AET) traded up $1.54 during trading hours on Tuesday, hitting $189.34. The company had a trading volume of 2,576,400 shares, compared to its average volume of 2,897,514. The company has a quick ratio of 0.53, a current ratio of 0.53 and a debt-to-equity ratio of 0.52. The stock has a market capitalization of $61,690.00, a P/E ratio of 35.00, a P/E/G ratio of 1.59 and a beta of 0.61. Aetna Inc has a 12 month low of $116.04 and a 12 month high of $192.37.

Aetna (NYSE:AET) last posted its earnings results on Tuesday, October 31st. The company reported $2.45 EPS for the quarter, topping analysts’ consensus estimates of $2.06 by $0.39. The company had revenue of $14.99 billion for the quarter, compared to the consensus estimate of $15.12 billion. Aetna had a return on equity of 21.84% and a net margin of 2.93%. The firm’s revenue for the quarter was down 5.0% on a year-over-year basis. During the same period in the previous year, the business earned $2.07 earnings per share. equities research analysts predict that Aetna Inc will post 9.78 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Thursday, January 11th will be paid a dividend of $0.50 per share. The ex-dividend date is Wednesday, January 10th. This represents a $2.00 annualized dividend and a yield of 1.06%. Aetna’s payout ratio is currently 36.97%.

Several research firms recently weighed in on AET. Deutsche Bank upgraded Aetna from a “hold” rating to a “buy” rating and lifted their target price for the company from $195.00 to $212.00 in a research report on Monday. Cantor Fitzgerald reiterated a “neutral” rating and set a $175.00 target price on shares of Aetna in a research report on Monday, October 23rd. Citigroup boosted their price objective on Aetna from $183.00 to $197.00 and gave the company a “buy” rating in a research report on Thursday, November 2nd. BMO Capital Markets boosted their price objective on Aetna from $175.00 to $200.00 and gave the company a “market perform” rating in a research report on Friday, October 27th. Finally, Zacks Investment Research downgraded Aetna from a “buy” rating to a “hold” rating in a research report on Tuesday, October 3rd. Eleven equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $175.09.

WARNING: “James Investment Research Inc. Has $14.80 Million Position in Aetna Inc (AET)” was published by Watch List News and is the sole property of of Watch List News. If you are reading this article on another publication, it was stolen and reposted in violation of United States & international copyright laws. The correct version of this article can be viewed at https://www.watchlistnews.com/james-investment-research-inc-has-14-80-million-position-in-aetna-inc-aet/1819964.html.

Aetna Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.